Search

To achieve malaria eradication, new preventative agents that act differently to front-line treatment drugs are needed. To identify potential chemoprevention starting points we screened a sub-set of the CSIRO Australia Compound Collection for compounds with slow-action in vitro activity against Plasmodium falciparum. This work identified N,N-dialkyl-5-alkylsulfonyl-1,3,4-oxadiazol-2-amines as a new antiplasmodial chemotype (e.g., 1 96 h IC 50 550 nM; 3 96 h IC 50 160 nM) with a different action to delayed-death slow-action drugs. A series of analogues were synthesized from thiotetrazoles and carbomoyl derivatives using Huisgen 1,3,4-oxadiazole synthesis followed by oxidation of the resultant thioethers to target sulfones. Structure activity relationship analysis of analogues identified compounds with potent and selective in vitro activity against drug-sensitive and multi-drug resistant Plasmodium parasites (e.g., 31 and 32 96 h IC 50 <40 nM; SI > 2500). Subsequent studies in mice with compound 1, which had the best microsomal stability of the compounds assessed (T 1/2 >255 min), demonstrated rapid clearance and poor oral in vivo efficacy in a P. berghei murine malaria model. These data indicate that while N,N-dialkyl-5-alkylsulfonyl-1,3,4-oxadiazol-2-amines are a novel class of slow-acting antiplasmodial agents, the further development of this chemotype for malaria chemoprophylaxis will require pharmacokinetic profile improvements., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Katherine Andrews, Tina Skinner-Adams, Oliver Hutt, John Ryan, Andrew Riches reports financial support was provided by National Health and Medical Research Council of Australia. Anjana Rai reports financial support was provided by Griffith University GUIPRS and GUPRS PhD scholarships. Katherine Andrews reports equipment, drugs, or supplies was provided by Australian Red Cross Lifeblood. Katherine Andrews reports writing assistance was provided by Monash Institute of Pharmaceutical Sciences Centre for Drug Candidate Optimisation. Katherine Andrews reports equipment, drugs, or supplies was provided by Compounds Australia, Griffith University. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)

Integrating multimodal neuro- and nanotechnology-enabled precision immunotherapies with extant systemic immunotherapies may finally provide a significant breakthrough for combatting glioblastoma (GBM). The potency of this approach lies in its ability to train the immune system to efficiently identify and eradicate cancer cells, thereby creating anti-tumor immune memory while minimizing multi-mechanistic immune suppression. A critical aspect of these therapies is the controlled, spatiotemporal delivery of structurally defined nanotherapeutics into the GBM tumor microenvironment (TME). Architectures such as spherical nucleic acids or poly(beta-amino ester)/dendrimer-based nanoparticles have shown promising results in preclinical models due to their multivalency and abilities to activate antigen-presenting cells and prime antigen-specific T cells. These nanostructures also permit systematic variation to optimize their distribution, TME accumulation, cellular uptake, and overall immunostimulatory effects. Delving deeper into the relationships between nanotherapeutic structures and their performance will accelerate nano-drug development and pave the way for the rapid clinical translation of advanced nanomedicines. In addition, the efficacy of nanotechnology-based immunotherapies may be enhanced when integrated with emerging precision surgical techniques, such as laser interstitial thermal therapy, and when combined with systemic immunotherapies, particularly inhibitors of immune-mediated checkpoints and immunosuppressive adenosine signaling. In this perspective, we highlight the potential of emerging treatment modalities, combining advances in biomedical engineering and neurotechnology development with existing immunotherapies to overcome treatment resistance and transform the management of GBM. We conclude with a call to action for researchers to leverage these technologies and accelerate their translation into the clinic., Competing Interests: Competing interests statement:A.B.H. serves on the advisory board of Caris Life Sciences and the WCG Oncology Advisory Board. She has received consulting fees from BlueRock Therapeutics and Novocure and been provided in-kind support for research from Moleculin, Takeda, ImmunoGenesis, and Carthera. A.H.K. is a consultant for Monteris Medical and has a received research grant from Stryker for a clinical outcomes study about a dural substitute, which has no direct relation to this study. A.H.S. is a shareholder of Exicure Inc., which develops SNA therapeutic platforms. A.H.S. and C.A.M. are inventors on patent US20150031745A1, which describes SNA nanoconjugates to cross the blood-brain barrier. A.B.H. receives royalty and milestone payments from DNAtrix for the licensing of the patent titled “Biomarkers and combination therapies using oncolytic virus and immunomodulation” (11,065,285). She additionally has active patents titled “miRNA for treating cancer and for use with adoptive immunotherapies” (9,675,633) and “Concurrent chemotherapy and immunotherapy” (9,399,662) “Low intensity ultrasound combination cancer therapies” (International applications PCT/US2022/019435 and US 63/158,642).

Cancer vaccines must activate multiple immune cell types to be effective against aggressive tumours. Here we report the impact of the structural presentation of two antigenic peptides on immune responses at the transcriptomic, cellular and organismal levels. We used spherical nucleic acid (SNA) nanoparticles to investigate how the spatial distribution and placement of two antigen classes affect antigen processing, cytokine production and the induction of memory. Compared with single-antigen SNAs, a single dual-antigen SNA elicited a 30% increase in antigen-specific T cell activation and a two-fold increase in T cell proliferation. Antigen placement within dual-antigen SNAs altered the gene expression of T cells and tumour growth. Specifically, dual-antigen SNAs encapsulating antigens targeting helper T cells and with externally conjugated antigens targeting cytotoxic T cells elevated antitumour genetic pathways, stalling lymphoma tumours in mice. Additionally, when combined with the checkpoint inhibitor anti-programmed-cell-death protein-1 in a mouse model of melanoma, a specific antigen arrangement within dual-antigen SNAs suppressed tumour growth and increased the levels of circulating memory T cells. The structural design of multi-antigen vaccines substantially impacts their efficacy., (© 2023. The Author(s), under exclusive licence to Springer Nature Limited.)

A series of 1-benzyloxy-5-phenyltetrazole derivatives and similar compounds were synthesized and evaluated for their in vitro inhibitory activity against androgen-receptor-dependent (22Rv1) and androgen-receptor independent (PC3) prostate cancer cells. The most active compounds had in vitro IC 50 values against 22Rv1 cells of <50 nM and showed apparent selectivity for this cell type over PC3 cells; however, these active compounds had short half-lives when incubated with mouse liver microsomes and/or when plasma concentration was monitored during in vivo pharmacokinetic studies in mice or rats. Importantly, lead compound 1 exhibited promising inhibitory effects on cell proliferation, expression of AR and its splicing variant AR-v7 as well as AR regulated target genes in 22Rv1 cells, which are so called castration-resistant prostate cancer (CRPC) cells, and a 22Rv1 CRPC xenograft tumour model in mice. Structural changes which omitted the N-O-benzyl moiety led to dramatic or total loss of activity and S-benzylation of a cysteine derivative, as a surrogate for in vivo S-nucleophiles, by representative highly active compounds, suggested a possible chemical reactivity basis for this "activity cliff" and poor pharmacokinetic profile. However, representative highly active compounds did not inhibit a cysteine protease, indicating that the mode of activity is unlikely to be protein modification by S-benzylation. Despite our efforts to elucidate the mode of action, the mechanism remains unclear., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Francis, Ali, Skidmore, Savage reports financial support was provided by Trailer Stonestar Pty Ltd. Wu, Xu, Zhao, Kong, Zhang, Liu reports financial support was provided by Guangzhou Yilai Biomedicine and Biotechnology Inc. Wu, Zhao, Xu, Zhang, Kong, Liu, Francis, Ali, Savage, has patent Tetrazole compounds and use thereof pending to GIBH and CSIRO., (Crown Copyright © 2022. Published by Elsevier Masson SAS. All rights reserved.)

The structure of N -methyl- N '-(pyridin-2-yl)benzene-1,2-di-amine, C 12 H 13 N 3 , at 123 K has ortho-rhom-bic ( Pna 2 1 ) symmetry. The title compound displays an unexpected proton-splitting pattern when studied by 1 H NMR spectroscopy. The X-ray crystallography analysis determined this to be caused by strong dual N-H⋯N hydrogen bonding., (© Collis et al. 2022.)

Competency in skills associated with collaborative problem solving (CPS) is critical for many contexts, including school, the workplace, and the military. Innovative approaches for assessing individuals' CPS competency are necessary, as traditional assessment types such as multiple -choice items are not well suited for such a process-oriented competency. In a move to computer-based environments to support CPS assessment, innovative computational approaches are also needed to understand individuals' CPS behaviors. In the current study, we describe the use of a simulation-based task on electronics concepts as an environment for higher education students to display evidence of their CPS competency. We further describe computational linguistic methods for automatically characterizing students' display of various CPS skills in the task. Comparisons between such an automated approach and an approach based on human annotation to characterize student CPS behaviors revealed above average agreement. These results give credence to the potential for automated approaches to help advance the assessment of CPS and to circumvent the time-intensive human annotation approaches that are typically used in these contexts.

Introducing a small phosphorus-based fragment into other molecular entities via, for example, phosphorylation/phosphonylation is an important process in synthetic chemistry. One of the approaches to achieve this is by trapping and subsequently releasing extremely reactive phosphorus-based molecules such as dioxophosphoranes. In this work, electron-rich hexaphenylcarbodiphosphorane ( CDP ) was used to stabilize the least thermodynamically favorable isomer of HO 2 P to yield monomeric CDP·PHO 2 . The title compound was observed to be a quite versatile phosphonylating agent; that is, it showed a great ability to transfer, for the first time, the HPO 2 fragment to a number of substrates such as alcohols, amines, carboxylic acids, and water. Several phosphorous-based compounds that were generated using this synthetic approach were also isolated and characterized for the first time. According to the initial computational studies, the addition-elimination pathway was significantly more favorable than the corresponding elimination-addition route for "delivering" the HO 2 P unit in these reactions.

The aminoacyl-tRNA synthetases are an ancient and ubiquitous component of all life. Many eukaryotic synthetases balance their essential function, preparing aminoacyl-tRNA for use in mRNA translation, with diverse roles in cell signaling. Herein, we use long-read sequencing to discover a leukocyte-specific exon skipping event in human leucyl-tRNA synthetase (LARS). We show that this highly expressed splice variant, LSV3, is regulated by serine-arginine-rich splicing factor 1 (SRSF1) in a cell-type-specific manner. LSV3 has a 71 amino acid deletion in the catalytic domain and lacks any tRNA leucylation activity in vitro. However, we demonstrate that this LARS splice variant retains its role as a leucine sensor and signal transducer for the proliferation-promoting mTOR kinase. This is despite the exon deletion in LSV3 including a portion of the previously mapped Vps34-binding domain used for one of two distinct pathways from LARS to mTOR. In conclusion, alternative splicing of LARS has separated the ancient catalytic activity of this housekeeping enzyme from its more recent evolutionary role in cell signaling, providing an opportunity for functional specificity in human immune cells., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)

Costimulatory receptors such as glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) play key roles in regulating the effector functions of T cells. In human clinical trials, however, GITR agonist antibodies have shown limited therapeutic effect, which may be due to suboptimal receptor clustering-mediated signaling. To overcome this potential limitation, a rational protein engineering approach is needed to optimize GITR agonist-based immunotherapies. Here we show a bispecific molecule consisting of an anti-PD-1 antibody fused with a multimeric GITR ligand (GITR-L) that induces PD-1-dependent and FcγR-independent GITR clustering, resulting in enhanced activation, proliferation and memory differentiation of primed antigen-specific GITR + PD-1 + T cells. The anti-PD-1-GITR-L bispecific is a PD-1-directed GITR-L construct that demonstrated dose-dependent, immunologically driven tumor growth inhibition in syngeneic, genetically engineered and xenograft humanized mouse tumor models, with a dose-dependent correlation between target saturation and Ki67 and TIGIT upregulation on memory T cells. Anti-PD-1-GITR-L thus represents a bispecific approach to directing GITR agonism for cancer immunotherapy., (© 2022. The Author(s).)

A 1,4,7,10-tetraazacyclododecane (cyclen) variant bearing two thiosemicarbazone pendant groups has been prepared. The ligand forms complexes with Mn 2+ , Co 2+ and Zn 2+ . X-ray crystallography of the Mn 2+ , Co 2+ and Zn 2+ complexes showed that the ligand provides a six-coordinate environment for the metal ions. The Mn 2+ and Zn 2+ complexes exist in the solid state as racemic mixtures of the Δ(δ,δ,δ,δ)/Λ(λ,λ,λ,λ) and Δ(λ,λ,λ,λ)/Λ(δ,δ,δ,δ) diastereomers, and the Co 2+ complex exists as the Δ(δ,δ,δ,δ)/Λ(λ,λ,λ,λ) and Δ(λ,λ,λ,δ)/Λ(δ,δ,δ,λ) diastereomers. Density functional theory calculations indicated that the relative energies of the diastereomers are within 10 kJ mol -1 . Magnetic susceptibility of the complexes indicated that both the Mn 2+ and Co 2+ ions are high spin. The ligand was radiolabelled with gallium-68, in the interest of developing new positron emission tomography imaging agents, which produced a single species in high radiochemical purity (>95%) at 90 °C for 10 min.

Alterations in genes encoding for proteins that control fucosylation are known to play causative roles in several developmental disorders, such as Dowling-Degos disease 2 and congenital disorder of glycosylation type IIc (CDGIIc). Recent studies have provided evidence that changes in fucosylation can contribute to the development and progression of several different types of cancers. It is therefore important to gain a detailed understanding of how fucosylation is altered in disease states so that interventions may be developed for therapeutic purposes. In this report, we find that fucosylation occurs on many intracellular proteins. This is an interesting finding, as the fucosylation machinery is restricted to the secretory pathway and is thought to predominately affect cell-membrane-bound and secreted proteins. We find that Ribosomal protein S3 (RPS3) is fucosylated in normal tissues and in cancer cells, and that the extent of its fucosylation appears to respond to stress, including MAPK inhibitors, suggesting a new role in posttranslational protein function. Our data identify a new ribosome-independent species of fucosylated RPS3 that interacts with proteins involved in posttranscriptional regulation of RNA, such as Heterogeneous nuclear ribonucleoprotein U (HNRNPU), as well as with a predominance of non-coding RNAs. These data highlight a novel role for RPS3, which, given previously reported oncogenic roles for RPS3, might represent functions that are perturbed in pathologies such as cancer. Together, our findings suggest a previously unrecognized role for fucosylation in directly influencing intracellular protein functions.

Oxidation of the anti-tumour agent [Pt{(p-BrC 6 F 4 )NCH 2 CH 2 NEt 2 }Cl(py)], 1 (py = pyridine) with hydrogen peroxide under a variety of conditions yields a range of organoenamineamidoplatinum(II) compounds [Pt{(p-BrC 6 F 4 )NCH=C(X)NEt 2 }Cl(py)] (X = H, Cl, Br) as well as species with shared occupancy involving H, Cl and Br. Thus, oxidation of the -CH 2 -CH 2 - backbone (dehydrogenation) occurs, often accompanied by substitution. Oxidation of 1 with H 2 O 2 in acetone yielded 1:1 co-crystallized [Pt{(p-BrC 6 F 4 )NCH=CHNEt 2 }Cl(py)], 1H and [Pt{(p-BrC 6 F 4 )NCH=C(Cl)NEt 2 }Cl(py)], 1Cl. The former was obtained pure in low yield from the oxidation of 1 with (NH 4 ) 2 [Ce(NO 3 ) 6 ] in acetone, and the latter was obtained from 1 and H 2 O 2 in CH 2 Cl 2 at near reflux. From the latter reaction under vigorous refluxing [Pt{(p-BrC 6 F 4 )NCH=C(Br)NEt 2 }Cl(py)], 1Br was isolated. In refluxing acetonitrile, oxidation of 1 with H 2 O 2 yielded [Pt{(p-BrC 6 F 4 )NCH=C(H 0 . 25 Br 0.75 )NEt 2 }Cl(py)], 1H 0.25 Br 0.75 , in which the alkene is mainly substituted by Br in a dual occupancy. Treatment of 1 with H 2 O 2 and tetrabutylammonium hydroxide in acetone at room temperature formed [Pt{(p-HC 6 F 4 )NCH 2 CH 2 NEt 2 }Cl(py)], 2. Oxidation of [Pt{(p-HC 6 F 4 )NCH 2 CH 2 NEt 2 }Br(py)], 3 with H 2 O 2 in boiling acetonitrile gave the ligand oxidation product [Pt{(p-HC 6 F 4 )NCH=C(Br)NEt 2 }Br(py)], 3Br. All major products were identified by X-ray crystallography as well as by 1 H and 19 F NMR spectra. In cases of mixed crystals or dual occupancy compounds, the 19 F and 1 H NMR spectra showed dissociation into the components in the solution in the same proportions as in isolated crystalline material., (Copyright © 2021 Elsevier Inc. All rights reserved.)

CTLA4-Ig/abatacept dampens activation of naive T cells by blocking costimulation via CD28. It is an approved drug for rheumatoid arthritis but failed to deliver efficacy in a number of other autoimmune diseases. One explanation is that activated T cells rely less on CD28 signaling and use alternate coreceptors for effector function. ICOS is critical for activation of T-dependent humoral immune responses, which drives pathophysiology of IgG-mediated autoimmune diseases. In this study, we asked whether CD28 and ICOS play nonredundant roles for maintenance of T-dependent responses in mouse models. Using a hapten-protein immunization model, we show that during an ongoing germinal center response, combination treatment with CTLA4-Ig and ICOS ligand (ICOSL) blocking Ab completely dissolves ongoing germinal center responses, whereas single agents show only partial activity. Next, we took two approaches to engineer a therapeutic molecule that blocks both pathways. First, we engineered CTLA4-Ig to enhance binding to ICOSL while retaining affinity to CD80/CD86. Using a library approach, binding affinity of CTLA4-Ig to human ICOSL was increased significantly from undetectable to 15-42 nM; however, the affinity was still insufficient to completely block binding of ICOSL to ICOS. Second, we designed a bispecific costimulation inhibitor with high-affinity CTLA4 extracellular domains fused to anti-ICOSL Ab termed bifunctional costimulation inhibitor. With this bispecific approach, we achieved complete inhibition of CD80 and CD86 binding to CD28 as well as ICOS binding to ICOSL. Such bispecific molecules may provide greater therapeutic benefit in IgG-mediated inflammatory diseases compared with CTLA4-Ig alone., (Copyright © 2021 by The American Association of Immunologists, Inc.)

CD137 (TNFRSF9, 4-1BB) agonist antibodies (mAb) have demonstrated potent antitumor activity with memory response while causing hepatotoxicity in mouse models. In clinical trials, the degrees of liver toxicity of anti-CD137 vary from grade 4 transaminitis (urelumab) to nonexistent (utomilumab). To exploit the antitumor potential of CD137 signaling, we identified a new class of CD137 agonist mAbs with strong antitumor potency without significant transaminitis in vivo compared with CD137 agonists previously reported. These mAbs are cross-reactive to mouse and cynomolgus monkey and showed cross-linking-dependent T-cell costimulation activity in vitro Antitumor efficacy was maintained in Fc gamma receptor (FcγR) III-deficient mice but diminished in FcγRIIB-deficient mice, suggesting the critical role for FcγRIIB to provide cross-linking in vivo Interestingly, a single dose of an affinity-reduced variant was sufficient to control tumor growth, but a higher affinity variant did not improve efficacy. These observations suggest that binding epitope and FcγR interaction, but not necessarily high affinity, are important for antitumor efficacy and reduced liver toxicity of CD137 mAb. Our study suggests the possibility of CD137 agonist therapy with improved safety profile in humans., (©2020 American Association for Cancer Research.)

Thermal energy storage technology utilizing phase-change materials (PCMs) can be a promising solution for the intermittency of renewable energy sources. This work describes a novel family of PCMs based on the pyrazolium cation, that operate in the 100-200 °C temperature range, offering safe, inexpensive capacity and low supercooling. Thermal stability and extensive cycling tests of the most promising PCM candidate, pyrazolium mesylate (T m =168±1 °C, ΔH f =160 J g -1 ±5 %, ΔH total v =495 MJ m -3 ±5 %) show potential for its use in thermal storage applications. Additionally, this work discusses the molecular origins of the high thermal energy storage capacity of these ionic materials based on their crystal structures, revealing the importance of hydrogen bonds in PCM performance., (© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)

The structural, magnetic and theoretical aspects are described for three triangular lanthanide complexes, [Tb(OH)(teaH 2 ) 3 (paa) 3 ]Cl 2 (1), [Dy(OH)(teaH 2 ) 3 (paa) 3 ]Cl 2 (2) and [Ho(OH)(teaH 2 ) 3 (paa) 3 ]Cl 2 (3), and a hexanuclear wheel of formula [Dy(pdeaH) 6 (NO 3 ) 6 ] (4) [teaH 3 = triethanolamine, paaH = N-(2-pyridyl)-acetoacetamide and pdeaH 3 = 3-[bis(2-hydroxyethyl)amino]propan-1-ol]. Each complex displays single molecule toroidal behaviour as rationalised using high-level ab initio calculations. Complexes 2 and 3 are the first examples of mixed moment single molecule toroidal complexes featuring non-Kramers ions.

We have synthesised twelve manganese(iii) dinuclear complexes, 1-12, in order to understand the origin of magnetic exchange (J) between the metal centres and the magnetic anisotropy (D) of each metal ion using a combined experimental and theoretical approach. All twelve complexes contain the same bridging ligand environment of one μ-oxo and two μ-carboxylato, that helped us to probe how the structural parameters, such as bond distance, bond angle and especially Jahn-Teller dihedral angle affect the magnetic behaviour. Among the twelve complexes, we found ferromagnetic coupling for five and antiferromagnetic coupling for seven. DFT computed the J and ab initio methods computed the D parameter, and are in general agreement with the experimentally determined values. The dihedral angle between the two Jahn-Teller axes of the constituent MnIII ions are found to play a key role in determining the sign of the magnetic coupling. Magneto-structural correlations are developed by varying the Mn-O distance and the Mn-O-Mn angle to understand how the magnetic coupling changes upon these structural changes. Among the developed correlations, the Mn-O distance is found to be the most sensitive parameter that switches the sign of the magnetic coupling from negative to positive. The single-ion zero-field splitting of the MnIII centres is found to be negative for complexes 1-11 and positive for complex 12. However, the zero-field splitting of the S = 4 state for the ferromagnetic coupled dimers is found to be positive, revealing a significant contribution from the exchange anisotropy - a parameter which has long been ignored as being too small to be effective.

The first cadmium-based ionic liquids (ILs) have been developed, along with a family of cadmium dialkyldithiocarbamate salts, (cation)[Cd(R2dtc)3], in the pursuit of single source molecular precursors that thermolyse to form cadmium sulfide. Pyrrolidinium cadmium dialkyldithiocarbamate salts, (C4C1py)[Cd(R2dtc)3], salts were established to be ILs through thorough thermal and structural investigation.

The preparation of ruthenium complexes with novel 2,2'-bipyridine (bpy) ligands bearing four carboxylic acid groups was investigated with a view to creating dyes containing more than two potential anchoring groups per bpy unit for attachment to a titania surface. Synthetic challenges are encountered upon using the 2,2'-bipyridine-3,3',4,4'-tetracarboxylic acid ligand because it readily decarboxylates. The use of the methyl esterified derivative (3) proved to be more successful for complex preparation, with a robust preparation of the [Ru(3) 2 Cl 2 ] complex identified with diglyme as the solvent. This complex was further converted into the thiocyanato complex, [Ru(3) 2 (NCS) 2 ], which could not be completely de-esterified. X-ray analysis of crystals obtained from a mixture of isomers for this complex provided data for the S,S- and N,S-coordinated isomers; both showed a twisted arrangement of the pyridine rings in the 2,2'-bipyridine-3,3',4,4'-tetracarboxylic acid ligand, owing to steric hinderance. Conversely, the isosteric 2,2'-bipyridine-4,4',5,5'-tetracarboxylic acid ligand was easily converted into the desired [Ru(2) 2 (NCS) 2 ] complex through a standard one-pot procedure in N,N-dimethylformamide solvent. All of the complexes presented herein exhibit a significant redshift for the metal to ligand charge-transfer bands, relative to the benchmark ruthenium dye N719 and derivatives thereof. All complexes exhibit a quasi-reversible process for the ruthenium(II/III) couple at approximately 0.4 V versus the ferrocene couple, comparable to analogous ruthenium dyes., (© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)

The reaction of [Fe II (L . ) 2 ](BF 4 ) 2 with Li 2 TCNQF 4 results in the formation of [Fe III (L - ) 2 ][TCNQF 4 . - ] (1) where L . is the radical ligand, 4,4-dimethyl-2,2-di(2-pyridyl)oxazolidine-N-oxide and TCNQF 4 is 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanoquinodimethane. This has been characterised by X-ray diffraction, Raman and Fourier transform infrared (FTIR) spectroscopy, variable-temperature magnetic susceptibility, Mössbauer spectroscopy and electrochemistry. X-ray diffraction studies, magnetic susceptibility measurements and Raman and FTIR spectroscopy suggest the presence of low-spin Fe III ions, the anionic form (L - ) of the ligand and the anionic radical form of TCNQF 4 ; viz. TCNQF 4 . - . Li 2 TCNQF 4 reduces the [Fe II (L . ) 2 ] 2+ dication, which undergoes a reductively induced oxidation to form the [Fe III (L - ) 2 ] + monocation resulting in the formation of [Fe III (L - ) 2 ][TCNQF 4 . - ] (1), the electrochemistry of which revealed four well-separated, diffusion-controlled, one-electron, reversible processes. Mössbauer spectroscopy and electrochemical measurements suggest the presence of a minor second species, likely to be [Fe II (L . ) 2 ][TCNQF 4 2- ]., (© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)

1,8-Cineole is an abundant natural product that has the potential to be transformed into other building blocks that could be suitable alternatives to petroleum-based chemicals. Mono-hydroxy-lation of 1,8-cineole can potentially occur at eight different carbon sites around the bicyclic ring system. Using cytochrome P450 monooxygenase CYP101J2 from Sphingobium yanoikuyae B2, the hy-droxy-lation can be regioselectively directed at the C atom adjacent to the methyl-substituted quaternary bridgehead atom of 1,8-cineole. The unambiguous location of the hydroxyl functionality and the stereochemistry at this position was determined by X-ray crystal analysis. The mono-hydroxy-lated compound derived from this microorganism was determined to be (1 S )-2a-hy-droxy-1,8-cineole (trivial name) or (1 S ,4 R ,6 S )-1,3,3-trimethyl-2-oxabi-cyclo-[2.2.2]octan-6-ol (V) (systematic), C 10 H 18 O 2 . In the solid state this compound exhibits an inter-esting O-H⋯O hydrogen-bonding motif.

Two new 5,12-disubstituted 2,3-di-ethyl-naphtho-[2,3- g ]quinoxaline-6,11-dione compounds were readily synthesized from the commercial dye quinizarin. For 2,3-diethyl-5,12-di-hydroxy-naphtho-[2,3- g ]quinoxaline-6,11-dione, (II), C 20 H 16 N 2 O 4 , the mol-ecule displays a near planar conformation and both hy-droxy groups participate in intra-molecular O-H⋯O(carbon-yl) hydrogen bonds. In the crystal, π-π ring inter-actions [minimum ring centroid separation = 3.5493 (9) Å] form stacks of co-planar mol-ecules down the c axis, while only minor inter-molecular C-H⋯O inter-actions are present. In contrast, in 2,3-diethyl-5,12-bis-(piperidin-1-yl)naphtho-[2,3- g ]quinoxaline-6,11-dione, (IV), C 30 H 34 N 4 O 2 , which contains two independent, but similar, mol-ecules in the asymmetric unit, the polycyclic cores have a significant twist, with dihedral angles of 29.79 (6) and 29.31 (7)° between the terminal rings and only minor inter-molecular C-H⋯O hydrogen-bonding inter-actions are present. Electron density associated with additional solvent mol-ecules disordered about a fourfold axis was accounted for using the SQUEEZE procedure in PLATON [Spek (2015 ▸). Acta Cryst. C 71 , 9-18].

An enantioselective N-heterocyclic carbene (NHC)-catalyzed diene regenerative (4 + 2) annulation has been achieved through the use of highly nucleophilic morpholinone-derived catalysts. The reaction proceeds with good to excellent yields, high enantioselectivity (most >92% ee), and good diastereoselectivity (most >7:1). The generality of the reaction is high, with 19 examples reported. The utility of the products has been examined with subsequent derivatization in Diels-Alder reactions using electron-poor dienophiles. Furthermore, interception of the proposed β-lactone intermediate has been achieved, allowing the synthesis of compounds bearing four contiguous stereocenters with high levels of enantio- and diastereoselectivity.

A closo-type 11-vertex osmaborane [1-(η(6)-pcym)-1-OsB10H10] (pcym = para-cymene) has been synthesized and characterized by single-crystal X-ray diffraction and elemental analysis, as well as by (11)B and (1)H NMR, UV-visible, and mass spectrometry. The redox chemistry has been probed by dc and Fourier transformed ac voltammetry and bulk reductive electrolysis in CH3CN (0.10 M (n-Bu)4NPF6) and by voltammetry in the ionic liquid N-butyl-N-methylpyrrolidinium bis(trifluoromethylsulfonyl)amide (Pyrr1,4-NTf2), which allows the oxidative chemistry of the osmaborane to be studied. A single-crystal X-ray diffraction analysis has shown that [1-(η(6)-pcym)-1-OsB10H10] is isostructural with other metallaborane compounds of this type. In CH3CN (0.10 M (n-Bu)4NPF6), [1-(η(6)-pcym)-1-OsB10H10] undergoes two well-resolved one-electron reduction processes with reversible potentials separated by ca. 0.63-0.64 V. Analysis based on a comparison of experimental and simulated ac voltammetric data shows that the heterogeneous electron transfer rate constant (k(0)) for the first reduction process is larger than that for the second step at GC, Pt, and Au electrodes. k(0) values for both processes are also larger at GC than metal electrodes and depend on the electrode pretreatment, implying that reductions involve specific interaction with the electrode surface. EPR spectra derived from the product formed by one-electron reduction of [1-(η(6)-pcym)-1-OsB10H10] in CH3CN (0.10 M (n-Bu)4NPF6) and electron orbital data derived from the DFT calculations are used to establish that the formal oxidation state of the metal center of the original unreduced compound is Os(II). On this basis it is concluded that the metal atom in [1-(η(6)-pcym)-1-OsB10H10] and related metallaboranes makes a 3-orbital 2-electron contribution to the borane cluster. Oxidation of [1-(η(6)-pcym)-1-OsB10H10] coupled to fast chemical transformation was observed at 1.6 V vs ferrocene(0/+) in Pyrr1,4-NTf2. A reaction scheme for the oxidation involving formation of [1-(η(6)-pcym)-1-OsB10H10](+), which rearranges to an unknown electroactive derivative, is proposed, and simulations of the voltammograms are provided.

The synthesis of a heterometallic octanuclear {Cr(III)4Dy(III)4} complex containing fluoride bridges displays SMM behaviour, with highly coercive magnetic hysteresis loops. Intriguingly multiple relaxation processes are revealed and the relaxation times are found to be longer compared to those of an analogous complex with the same metallic core topology.

In seeking new drugs for the treatment of the parasitic disease Leishmaniasis, an extensive range of organometallic antimony(v) dicarboxylates of the form [SbR3(O2CR')2] have been synthesised, characterised and evaluated. The organometallic moieties (R) in the complexes vary in being Ph, tolyl (o, m or p), or benzyl. The carboxylates are predominantly substituted benzoates with some compounds incorporating acetato or cinnamato ligands. The crystal structures of [Sb(p-Tol)3(O2CC6H2-3,4,5-(OMe)3)2]·0.5PhMe and [SbPh3(m-CH3C6H4CH2CO2)2] were determined and shown to adopt a typical trigonal pyramidal geometry, being monomeric with a five coordinate Sb centre. In total, the biological activity of 26 Sb(v) compounds was assessed against the Leishmania major parasite, and also human fibroblast skin cells to give a measure of general toxicity. Of these, 11 compounds (predominantly substituted benzoates with m- or p-tolyl ligands) proved to be highly effective against the parasite amastigotes at concentrations of 0.5-3.5 μM, while being non-toxic towards the mammalian cells at levels below 25 μM, making them highly promising drug candidates.

The title compound, C28H40N2O2S2, was obtained as a minor product from an anti-aldol reaction between the corresponding N-propionyl-thiol-actam and benzaldehyde. The asymmetric unit contains one half-molecule, which is completed by inversion symmetry. The molecule displays a nearly eclipsed conformation along the central C-C bond with a C-C-C-C- torsion angle of 20.4 (3)°.

A structure-device performance correlation in bulk heterojunction solar cells for new indandione-derived small molecule electron acceptors, FEHIDT and F8IDT, is presented. Devices based on the former exhibit higher power conversion efficiency (2.4%) and higher open circuit voltage, a finding consistent with reduced intermolecular interactions.

Calcium and strontium metals react with Hg(C6F5)2 and 2,4-di-tert-butylphenol (H-DBP) in tetrahydrofuran (THF) and 1,2-dimethoxyethane (DME) to give [Ca(DBP)2(THF)4] (1), [Ca2(DBP)4(DME)4(μ-DME)] (2), [Sr3(μ-DBP)6(THF)6] (3), and [Sr2(DBP)(μ-DBP)3(DME)3] (4). Compound 1 is a six coordinate trans-octahedral monomer, whereas in binuclear 2 two seven-coordinate Ca centres are bridged by a DME ligand. In 3 a central Sr is connected by three bridging DBP groups to each of two terminal Sr(THF)3 moieties, all metal atoms being six coordinate. Compound 4 has one six- and one seven-coordinate Sr, bridged by three DBP ligands, the former Sr also having a terminal DBP and a bidentate DME ligand and the latter two DME ligands. Complexes 2 and 4 act as ring-opening polymerisation (ROP) catalysts for the benzyl alcohol or benzylamine co-initiated ROP rac-lactide forming atactic alcohol- or amine-terminated polylactide H-[PLA]-XBn (X = O or NH) with reasonable control of molecular weight via an activated monomer propagation mechanism. Kinetic studies for BnNH2 found the unusual rate expression -d[LA]/dt = k(p(Ae))[2 or 4]0[rac-LA](2)[BnNH2]0(2.5) (k(p(Ca)) ≈ 1.7 ×k(p(Sr))). Preliminary studies suggest that [Y(DBP)3(THF)2] also catalyses amine or alcohol co-initiated ROP by an activated monomer mechanism without loss of a phenoxide ligand.

We developed a method for deep mutational scanning of antibody complementarity-determining regions (CDRs) that can determine in parallel the effect of every possible single amino acid CDR substitution on antigen binding. The method uses libraries of full length IgGs containing more than 1000 CDR point mutations displayed on mammalian cells, sorted by flow cytometry into subpopulations based on antigen affinity and analyzed by massively parallel pyrosequencing. Higher, lower and neutral affinity mutations are identified by their enrichment or depletion in the FACS subpopulations. We applied this method to a humanized version of the anti-epidermal growth factor receptor antibody cetuximab, generated a near comprehensive data set for 1060 point mutations that recapitulates previously determined structural and mutational data for these CDRs and identified 67 point mutations that increase affinity. The large-scale, comprehensive sequence-function data sets generated by this method should have broad utility for engineering properties such as antibody affinity and specificity and may advance theoretical understanding of antibody-antigen recognition.

The first enantioselective synthesis of the proposed relative structures of Prevezol C is reported in 11 linear steps from readily available materials. The unusual syn bromohydrin was installed via a multistep sequence culminating in a diastereoselective geminal dibromide reduction. Discrepancies in the spectral data of the synthetic materials and the natural sample have led to the conclusion that the proposed structures are incorrect.

New reactive, divalent lanthanoid formamidinates [Yb(Form)(2)(thf)(2)] (Form=[RNCHNR]; R=o-MeC(6)H(4) (o-TolForm; 1), 2,6-Me(2)C(6)H(3) (XylForm; 2), 2,4,6-Me(3)C(6)H(2) (MesForm; 3), 2,6-Et(2)C(6)H(3) (EtForm; 4), o-PhC(6)H(4) (o-PhPhForm; 5), 2,6-iPr(2)C(6)H(3) (DippForm; 6), o-HC(6)F(4) (TFForm; 7)) and [Eu(DippForm)(2)(thf)(2)] (8) have been prepared by redox transmetallation/protolysis reactions between an excess of a lanthanoid metal, Hg(C(6)F(5))(2) and the corresponding formamidine (HForm). X-ray crystal structures of 2-6 and 8 show them to be monomeric with six-coordinate lanthanoid atoms, chelating N,N'-Form ligands and cis-thf donors. However, [Yb(TFForm)(2)(thf)(2)] (7) crystallizes from THF as [Yb(TFForm)(2)(thf)(3)] (7a), in which ytterbium is seven coordinate and the thf ligands are "pseudo-meridional". Representative complexes undergo C-X (X=F, Cl, Br) activation reactions with perfluorodecalin, hexachloroethane or 1,2-dichloroethane, and 1-bromo-2,3,4,5-tetrafluorobenzene, giving [Yb(EtForm)(2)F](2) (9), [Yb(o-PhPhForm)(2)F](2) (10), [Yb(o-PhPhForm)(2)Cl(thf)(2)] (11), [Yb(DippForm)(2)Cl(thf)] (12) and [Yb(DippForm)(2)Br(thf)] (16). X-ray crystallography has shown 9 to be a six-coordinate, fluoride-bridged dimer, 12 and 16 to be six-coordinate monomers with the halide and thf ligands cis to each other, and 11 to have a seven-coordinate Yb atom with "pseudo-meridional" unidentate ligands and thf donors cis to each other. The analogous terbium compound [Tb(DippForm)(2)Cl(thf)(2)] (13), prepared by metathesis, has a similar structure to 11. C-Br activation also accompanies the redox transmetallation/protolysis reactions between La, Nd or Yb metals, Hg(2-BrC(6)F(4))(2), and HDippForm, yielding [Ln(DippForm)(2)Br(thf)] complexes (Ln=La (14), Nd (15), Yb (16))., (Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)

Dye-sensitized solar cells (DSCs) are an attractive renewable energy technology currently under intense investigation. In recent years, one area of major interest has been the exploration of alternatives to the classical iodide/triiodide redox shuttle, with particular attention focused on cobalt complexes with the general formula [Co(L)(n)](2+/3+). We introduce a new approach to designing redox mediators that involves the application of [Co(PY5Me(2))(MeCN)](2+/3+) complexes, where PY5Me(2) is the pentadentate ligand, 2,6-bis(1,1-bis(2-pyridyl)ethyl)pyridine. It is shown, by X-ray crystallography, that the axial acetonitrile (MeCN) ligand can be replaced by more strongly coordinating Lewis bases (B) to give complexes with the general formula [Co(PY5Me(2))(B)](2+/3+), where B = 4-tert-butylpyridine (tBP) or N-methylbenzimidazole (NMBI). These commonly applied DSC electrolyte components are used for the first time to fine-tune the potential of the redox couple to the requirements of the dye through coordinative interactions with the Co(II/III) centers. Application of electrolytes based on the [Co(PY5Me(2))(NMBI)](2+/3+) complex in combination with a commercially available organic sensitizer has enabled us to attain DSC efficiencies of 8.4% and 9.2% at a simulated light intensity of 100% sun (1000 W m(-2) AM1.5 G) and at 10% sun, respectively, higher than analogous devices applying the [Co(bpy)(3)](2+/3+) redox couple, and an open circuit voltage (V(oc)) of almost 1.0 V at 100% sun for devices constructed with the tBP complex.

Sequestration of peroxide derived from molecular oxygen has resulted in the templated synthesis of a terbium picolinate cluster, isolated as a 2D sodiated network in the solid state. This first example of an air-stable rare-earth peroxide cluster represents key evidence for a peroxide-containing intermediate in rare-earth-cluster-catalyzed oxidation reactions. Luminescent and magnetic properties have also been investigated.

Treatment of Bi(2)O(3) with the acids; S-(+)-10-camphorsulfonic, 2,4,6-mesitylenesulfonic and sulfamic, under sonication at room temperature in water for 2-4 h, results in the formation and subsequent crystallisation of polynuclear bismuth oxido-clusters; [Bi(18)O(12)(OH)(12)(O(3)S-Cam)(18)(H(2)O)(2)], [Bi(38)O(45)(O(3)S-Mes)(24)(H(2)O)(14)] and [Bi(6)O(4)(OH)(4)(O(3)SNH(2))(6)].

A new class of homoleptic organoamido rare earth complexes [Ln(L(Me) or L(Et))(3)] (Ln = La, Ce, Nd; L(Me/Et) = p-HC(6)F(4)N(CH(2))(2)NMe(2)/Et(2)) exhibiting (Ar)CF-Ln interactions has been isolated from redox-transmetallation/protolysis (RTP) reactions between the free metals, Hg(C(6)F(5))(2) and L(Me/Et)H in tetrahydrofuran, together with low yields of [Ln(L(Me))(2)F](3) (Ln = La, Ce) or [Nd(L(Et))(2)F](2) species, resulting from C-F activation reactions. The structures of the homoleptic complexes have eight-coordinate Ln metals with two tridentate (N,N',F) amide ligands including (Ar)CF-Ln bonds and either a bidentate (N,F) ligand (Ln = La, Ce, Nd; L(Et)) or a bidentate (N,N') ligand (Ln = Nd; L(Me)), in an unusual case of linkage variation. All (Ar)CF-Ln bond lengths are shorter than or similar to the corresponding Ln-NMe(2)/Et(2) bond lengths. In [Ln(L(Me))(2)F](3) (Ln = La, Ce) complexes, there is a six-membered ring framework with alternating F and Ln atoms and the metal atoms are eight-coordinate with two tridentate (N,N',F) L(Me) ligands, whilst [Nd(L(Et))(2)F](2) is a fluoride-bridged dimer.

Understanding the ion transport behavior of organic ionic plastic crystals (OIPCs) is crucial for their potential application as solid electrolytes in various electrochemical devices such as lithium batteries. In the present work, the ion transport mechanism is elucidated by analyzing experimental data (single-crystal XRD, multinuclear solid-state NMR, DSC, ionic conductivity, and SEM) as well as the theoretical simulations (second moment-based solid static NMR line width simulations) for the OIPC diethyl(methyl)(isobutyl)phosphonium hexafluorophosphate ([P(1,2,2,4)][PF(6)]). This material displays rich phase behavior and advantageous ionic conductivities, with three solid-solid phase transitions and a highly "plastic" and conductive final solid phase in which the conductivity reaches 10(-3) S cm(-1). The crystal structure shows unique channel-like packing of the cations, which may allow the anions to diffuse more easily than the cations at lower temperatures. The strongly phase-dependent static NMR line widths of the (1)H, (19)F, and (31)P nuclei in this material have been well simulated by different levels of molecular motions in different phases. Thus, drawing together of the analytical and computational techniques has allowed the construction of a transport mechanism for [P(1,2,2,4)][PF(6)]. It is also anticipated that utilization of these techniques will allow a more detailed understanding of the transport mechanisms of other plastic crystal electrolyte materials.